Q-Interline (QINTER) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
19 Aug, 2026Company overview and market position
Q-Interline specializes in NIR spectroscopy instruments for process and product quality optimization in food, feed, dairy, agriculture, pharma, and chemical industries.
Over 700 systems delivered in 44 countries, with 35 employees and 27 years of experience.
2023 revenue reached DKK 32 million, with a 2024 target of DKK 40–45 million.
Listed on Nasdaq First North Growth since 2021.
Product and technology highlights
Offers maintenance-free, cloud-monitored NIR analyzers for both lab and in-line use, measuring liquids and solids.
Patented milk analyzer and unique measurement accessories; robust, user-friendly technology.
Over 50 in-line systems sold globally; can monitor multiple process lines with one system.
Four global competitors in the milk analyzer segment; patented Pivette® cell.
Financial performance and guidance
2023 revenue grew 22.4% to DKK 31.9 million; ARR share at 36%, up 21% from 2022.
Market capitalization at DKK 110.3 million, up 3% year-on-year.
2024 guidance: revenue DKK 40–45 million, EBIT between DKK -8.5 million and DKK -5.2 million.
ARR revenue expected to grow 25–40% in 2024.
Latest events from Q-Interline
- Revenue up 39% and EBIT improved 41%, driven by strong subsidiary growth and cost savings.QINTER
H1 2026 - ARR growth stabilized earnings despite lower system sales; strong backlog supports 2026 outlook.QINTER
H2 2025 - ARR growth of 37.2% offsets weak H1 sales; guidance lowered, but outlook remains positive.QINTER
H1 2025 - Recurring revenue and new market wins offset lower distributor sales; 2024 outlook unchanged.QINTER
H1 2024 - 22% revenue growth and strong ARR, but EBIT loss due to high investments; 2025 outlook positive.QINTER
H2 2024